VPDC

Diseases

What is Mumps?Updated 7-2-2026
  • Mumps is a contagious disease caused by a virus that is best known for causing puffy cheeks and a tender, swollen jaw (also known as parotitis).
  • Mumps can cause serious long-term health problems. There is no treatment for mumps.
  • Mumps can be prevented with the measles-mumps-rubella vaccine (MMR) or measles-mumps-rubella-varicella vaccine (MMRV). Two doses are about 88% effective at preventing mumps.
Mumps FAQ Document

Fact Sheet

English | More Languages
Mumps: Symptoms and Complications

Common symptoms for mumps include:

  • Swollen glands under the ears or jaw (parotitis)
  • Fever
  • Headache
  • Muscle aches
  • Tiredness
  • Loss of appetite

Mumps can cause several health complications, especially for adults, including:

  • Swelling of the testicles in men who have reached puberty (also called orchitis – rarely, this can lead to the testicles atrophying and/or the inability to have children)
  • Inflammation of one or both ovaries (oophoritis)
  • Swelling of breast tissue (mastitis)
  • Swelling of the brain (encephalitis)
  • Swelling of the tissue that covers the brain and spinal cord (meningitis)
  • Deafness (temporary or permanent)
  • Inflammation of the pancreas (pancreatitis)
How does Mumps Spread?
Child coughing

Mumps spreads from person to person through direct contact with saliva or respiratory droplets from the mouth, nose, or throat. A person infected with mumps can spread the virus by:

  • Coughing, sneezing, or talking
  • Sharing items that may have saliva on them such as utensils or water bottles
  • Participating in close contact activities with others such as sports or kissing

A person with mumps can spread the disease up to 2 days before their swelling starts and up to 5 days after their swelling starts.

What Should I Do if I Think I Have Mumps?

If you are confirmed to have mumps, you should stay away from other people until the 6th day after your swelling started. This will help make sure that you do not spread mumps to others.

If you think you or someone in your family may have mumps because you or they have symptoms, have not been vaccinated against mumps, and/or have been traveling:

  • Stay home and call your doctor right away and let them know of your concerns.
  • Your doctor may be able to determine if you have protection against mumps based on your vaccine record or previous lab results.
  • Your doctor may also make special arrangements to evaluate you to limit risk to other patients and staff. If your doctor tells you to come in for testing, make sure to wear a facemask that covers your nose and mouth.
  • Stay away from other people and stay away from places where there are large groups of people who are at higher risk of getting sick, such as schools, daycare, and hospital or urgent care waiting rooms, before speaking to your doctor. This will help make sure that you do not spread mumps to others.

If you think you have been exposed to someone with mumps:

  • Call your doctor right away to let them know you may have been exposed to someone with mumps.
  • Your doctor may be able to determine if you have protection against mumps based on your vaccine record or previous lab results.
  • Your doctor may also make special arrangements to evaluate you to limit risk to other patients and staff. If your doctor tells you to come in for testing, make sure to wear a facemask that covers your nose and mouth.
  • Do not leave your home until your doctor says it is okay. Stay away from places where there are large groups of people who are at higher risk of getting sick, such as schools, daycare, and hospital or urgent care waiting rooms. This will help make sure that you do not spread mumps to others.
Information for the Public
Vaccine Information

The mumps vaccine is safe and works well in preventing mumps. Everyone including children, teenagers, and adults should get two doses of mumps vaccine if they were never vaccinated.

One dose of a mumps vaccine is about 78% effective, and two doses are about 88% effective at preventing mumps. However, vaccine effectiveness can vary between individuals, and protection may wane over time. Because of this, even fully vaccinated individuals who develop symptoms of mumps should still be tested for mumps.

There are two types of mumps vaccines:

  • Measles-mumps-rubella vaccine (MMR) for people who are 12 months old and older.
  • Measles-mumps-rubella-varicella vaccine (MMRV) for people who are 12 months to 12 years old.
Vaccine Recommendations

Mumps can be prevented with MMR or MMRV vaccines. California requires that children get at least one dose of the MMR or MMRV vaccine before starting school or childcare.

The American Academy of Pediatrics (AAP) recommends that children get two doses of MMR or MMRV vaccine:

  • Dose 1 at 12-15 months old, and Dose 2 at 4-6 years old (before starting kindergarten).
    • Children can get the second dose earlier as long as it is at least 28 days after the first dose.
  • Infants 6-11 months old should get one dose of the MMR vaccine before traveling internationally or traveling to a place with a mumps outbreak.
    • Infants who get one dose of the MMR vaccine before they are 12 months old should get two more doses of the MMR or MMRV vaccine at 12-15 months old and at 4-6 years old.

Other vaccines can be given at the same time as the MMR or MMRV vaccine.

Who SHOULD get the vaccine:

  • Anyone born in 1957 or later who has never had mumps or has never been vaccinated against mumps should get two doses of MMR vaccine.
    • Children 12 months through 12 years old can get either MMR or MMRV vaccine.
  • Any adults who do not have immunity to mumps, especially adults at higher risk – for example, students in post-high school education institutions, healthcare personnel, and international travelers.
  • Anyone who is in an area with a mumps outbreak can get a third dose of MMR vaccine for added protection.

Who should NOT get the vaccine:

  • Anyone with a severe, life-threatening allergy or who has had an allergic reaction to any part of the MMR or MMRV vaccine
  • Anyone with a severely weakened immune system, or who has a parent, brother, or sister with a severely weakened immune system (unless you have been verified by a doctor to not have the same condition)
  • Anyone who is pregnant or who may become pregnant in the next four weeks

Who should talk to their doctor in case they need to wait to get the vaccine:

  • Anyone who got an antibody-containing blood product (like immune globulin/IG) less than a year ago
  • Anyone who is currently sick, whether or not you have a fever
  • Anyone who needs to get tested for tuberculosis in the next four weeks

Talk to your doctor if you have any of these health conditions or other precautions for vaccination. Learn more about who should get the MMR or MMRV vaccine.

Where to Get the Vaccine

If you have insurance:

  • Talk to your doctor or check with your local pharmacy to see what vaccines they offer.
  • Most health insurance plans cover the cost of recommended vaccines for children and adults.

If you are uninsured or underinsured:

  • Programs are available to help cover the cost of vaccines.
  • Children 18 years or younger may receive vaccines at no cost through the Vaccines for Children (VFC) Program if they are:
    • Eligible for or are enrolled in Medi-Cal
    • American Indian or Alaskan Native
    • Uninsured (do not have health insurance)
    • Underinsured (private health insurance does not cover the full cost of vaccines)
  • Adults who are uninsured or underinsured may be able to get free or low-cost vaccines at clinics enrolled in the Vaccines for Adults (VFA) program. For more information on who is eligible, read VFA Eligibility Based on Insurance Status.

Locating Vaccine Clinics:

  • A list of free and low-cost clinics in Los Angeles County.
  • Interactive county map to locate free and low-cost vaccine clinics.
  • Call 1-833-540-0473 (Public Health InfoLine) for a list of free or low-cost vaccine clinics. This includes Vaccines for Children (VFC) provider locations that serve Medi-Cal eligible children and uninsured or underinsured adults.
Keeping Track of Your Immunization Records

If you are unsure of your mumps vaccination status, you can request a copy of your records.

To request your record:

If your vaccines are not listed, ask your doctor, pharmacist, or vaccine provider for a copy of your vaccine records. You can also ask them to add your vaccines to the California Immunization Registry (CAIR).

Other tips to find your records:

Additional Resources
Information for Providers
Clinical Presentation

Mumps cases continue to occur in the United States and can lead to serious complications. It is important to consider mumps when evaluating any vaccinated or unvaccinated patient who presents any of the traditional mumps symptoms.

  • Prodromal symptoms typically appear 16-18 days (with a range of 12 to 25 days) after exposure and begins with a low-grade fever, headache, myalgia, fatigue, and anorexia. Prodromal symptoms are then most commonly followed by parotitis (or other salivary gland swelling) which lasts 5 days on average. Salivary gland swelling, pain and tenderness occur within 48 hours of prodrome onset. Symptoms tend to decrease after 1 week and usually resolve after 10 days.
    • 40-50% of people who get mumps have very mild symptoms (like a cold) or no symptoms and may not know they have the disease.
  • Complications may include: orchitis, oophoritis, mastitis, pancreatitis, hearing loss, or neurologic manifestations including meningitis and encephalitis.
  • Mumps is transmitted through respiratory secretions or droplets from the respiratory tract, and sometimes through fomites. A person with mumps is considered contagious 2 days before parotitis onset until 5 days after.
Isolation of Suspected Cases
  • Patients with signs or symptoms of mumps should be isolated from other patients prior to or as soon as possible after entry into the facility.
  • Patients with suspected mumps should wear a well-fitted medical mask or respirator and be placed in an airborne infection isolation room if one is available. If an isolation room is not available, escort masked patient away from other patients directly to a private room for evaluation and specimen collection.
  • Regardless of prior immunity status, all healthcare staff entering the same room as the patient should use respiratory protection consistent with airborne infection control precautions.
  • Although the mumps virus has been isolated from saliva up to 9 days after onset, isolation beyond 5 days is not currently recommended.
Disease Reporting

Please contact the LAC DPH Vaccine-Preventable Disease Control Program to report a case or obtain any other technical assistance with specimen collection or completion of forms for mumps or any other vaccine-preventable disease.

Suspected or confirmed mumps cases are to be reported within 7 calendar days from identification by electronic transmission (email or digital fax) or telephone per Title 17, California Code of Regulations (CCR), Section 2500.

  • Weekdays Telephone: 8:30 am to 5:00 pm: Call 213-351-7800
  • After Hours: Call 213-974-1234, option 8
  • Email: vpdc@ph.lacounty.gov
  • Fax number: 213-351-2782

Please send the patient’s medical records and any available immunization records and/or laboratory results via secure email or fax.

Diagnostic Testing

Consultation with VPDC is required before sending specimens to the Public Health Laboratory. Follow the Checklist for Managing Patients Suspected of Having Mumps for specific instructions.

  • Buccal Swab for Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) testing: Collect buccal swab specimen within 3-9 days of parotitis onset or clinical suspicion of mumps. CDPH recommends collecting the specimen as soon as possible, ideally within the first 3 days, to optimize viral detection.
    • Store buccal swab specimen refrigerated at 2-8C. Transport refrigerated on cold packs to the laboratory as soon as possible within 24 hours of collection.
    • If storage beyond 24 hours is necessary, freeze specimen at -20°C or lower and transport frozen on dry ice.
  • Serum for Serology Antibody IgM/IgG testing: Supplemental to RT-PCR testing, the optimal time for serum specimen collection is 4 or more days after symptom onset.
    • Serum specimens should be refrigerated at 2-8°C within 8 hours of collection and may be stored at this temperature for up to 48 hours.
    • If storage beyond 48 hours is necessary, the serum should be frozen at -20°C or lower. Serum specimens can be stored frozen for up to 8 weeks.

If a commercial lab cannot perform testing, please call the Los Angeles County Department of Public Health Vaccine-Preventable Disease Control Program at 213-351-7800 for assistance.

Post-Exposure Prophylaxis

There is no post-exposure prophylaxis available for mumps. However, vaccination after exposure with mumps-containing vaccines (MMR or MMRV) is not harmful and may possibly prevent subsequent disease if re-exposed.

Treatment

There is no treatment for mumps. Mumps generally self-resolves, and therapy is symptom-based and supportive, such as the use of analgesics as needed. Standard immunoglobulin or gamma-globulin preparations do not appear to be effective treatment options based on the available research to date.

Vaccine Recommendations

The American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP) recommend that persons who do not have presumptive evidence of immunity should get vaccinated. Vaccination is the best way to prevent mumps and complications from disease.

MMR and MMRV Vaccine Recommendations for Children and Adults

Mumps-Containing Vaccines and Brands Number of Doses Age for Primary Series Recommended Age Dose & Route
Dose 1 Dose 2
M-M-R II® | PRIORIX®
(Measles-Mumps-Rubella)*
Merck | GlaxoSmithKline (GSK)
2** 12-15 mos
4-6 yrs and/or 4 wks after Dose 1 ≥12 mos** 0.5 mL Subcutaneous (SQ) or Intramuscular (IM)***,†
≥ 19 yrs At least 4 wks after Dose 1
ProQuad®
(Measles-Mumps-Rubella-Varicella)‡
Merck
2 12-47 mos 4-6 yrs and/or at least 3 mos after Dose 1 12 mos-12 yrs 0.5 mL IM or SQ†
*M-M-R®II and PRIORIX® are fully interchangeable for all indications for which MMR vaccination is recommended.
**An additional dose may be indicated in mumps outbreak situations and travel where mumps exposure is likely. Doses given before 12 months are invalid. May receive 1st dose of MMR 4 days before 1st birthday.
***PRIORIX® should only be given subcutaneously.
†The preferred injection site in small children is the anterolateral aspect of the thigh. The posterior triceps aspect of the upper arm is the preferred site for older children, adolescents and adults.
‡ProQuad® is only licensed for use in children 12 months through 12 years of age. It may be given at the same time as other vaccines. ProQuad® is associated with a higher risk for fever and febrile seizures in children 12-23 months of age.

MMR Vaccine Recommendations for Mumps Outbreaks and High Risk Settings
A third dose of a mumps virus-containing vaccine may be recommended during mumps outbreaks for individuals who have already received 2 doses, but who are identified by public health authorities as part of a group at increased risk for mumps. This recommendation specifically pertains to mumps outbreaks, not mumps exposure. In general, adults without presumptive evidence of immunity should receive at least 1 dose of the MMR vaccine, and certain adults may need 2 doses depending on their risk factors.

  • Adults who are going to be in a setting that poses a high risk for mumps transmission should make sure they have had two doses separated by at least 28 days.

Pregnancy is a contraindication to vaccination with live virus vaccines, including MMR. The American College of Obstetricians & Gynecologists (ACOG) recommends avoiding pregnancy for 4 weeks after receipt of MMR.

Vaccine Reporting, Storage and Handling

Administration Data: California healthcare providers are required to report data on all valid immunizations that they administer to their patients into the California Immunization Registry (CAIR) within 2 weeks of administration per AB 1797.

Administration Errors: Healthcare providers are strongly recommended to report all vaccine administration errors to the Institute for Safe Medication Practices.

Adverse Events: Healthcare providers are required to report any adverse event on the reportable events list to the Vaccine Adverse Event Reporting System (VAERS) per HR 5546.

Storage and Handling: For general recommendations and guidance access the Vaccine Storage and Handling Job Aids.

Additional Resources


Adobe Reader

Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. Document functionality may be reduced if you are using an earlier version (4.x or less). Get the latest version of Adobe Acrobat.

  • Home  |
  • Careers  |
  • DPH Programs  |
  • Email: Webmaster  |
  • Notice of Privacy Practices | 
  • Website Privacy Policy  |
  • Accessibility  |
  • Disclaimer  |
  • Employee


  • Public Health has made reasonable efforts to provide accurate translation. However, no computerized translation is perfect and is not intended to replace traditional translation methods. If questions arise concerning the accuracy of the information, please refer to the English edition of the website, which is the official version.

    Los Angeles County Seal: Enriching lives through effective and caring services